Literature DB >> 25427966

A new metabolite panel test for identification of patients with impaired glucose tolerance? Analysis of the article by Cobb et al.

Andreas Pfützner1.   

Abstract

The article by Cobb et al represents solid research work applying the most sophisticated laboratory technologies, a very sound clinical research methodology, and valid statistical analysis procedures. The authors have identified a combination of metabolites suitable to replace the oral glucose tolerance test procedure in the identification of patients with impaired glucose tolerance (IGT) from a fasting blood draw. However, the discussed pathophysiological, clinical, and economic aspects may induce mechanisms restricting the probability of a global acceptance of this test for daily routine.
© 2014 Diabetes Technology Society.

Entities:  

Keywords:  IQ-IGT metabolite panel; impaired glucose tolerance; metabolomics; oral glucose tolerance test

Mesh:

Substances:

Year:  2014        PMID: 25427966      PMCID: PMC4495538          DOI: 10.1177/1932296814560789

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  9 in total

1.  A novel test for IGT utilizing metabolite markers of glucose tolerance.

Authors:  Jeff Cobb; Andrea Eckhart; Regis Perichon; Jacob Wulff; Matthew Mitchell; Klaus-Peter Adam; Robert Wolfert; Eric Button; Kay Lawton; Robert Elverson; Bernadette Carr; Margaret Sinnott; Ele Ferrannini
Journal:  J Diabetes Sci Technol       Date:  2014-09-26

Review 2.  Glucose toxicity.

Authors:  L Rossetti; A Giaccari; R A DeFronzo
Journal:  Diabetes Care       Date:  1990-06       Impact factor: 19.112

Review 3.  Metabolic profiling in diabetes.

Authors:  Karsten Suhre
Journal:  J Endocrinol       Date:  2014-06       Impact factor: 4.286

Review 4.  Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effects.

Authors:  Andreas Pfützner; Christian A Schneider; Thomas Forst
Journal:  Expert Rev Cardiovasc Ther       Date:  2006-07

5.  Impaired glucose tolerance and diabetes--WHO criteria.

Authors: 
Journal:  Br Med J       Date:  1980-12-06

Review 6.  Emerging economies and diabetes and cardiovascular disease.

Authors:  Rajendra Pradeepa; Dorairaj Prabhakaran; Viswanathan Mohan
Journal:  Diabetes Technol Ther       Date:  2012-06       Impact factor: 6.118

Review 7.  Metabolomics in diabetes.

Authors:  Ai-hua Zhang; Shi Qiu; Hong-ying Xu; Hui Sun; Xi-jun Wang
Journal:  Clin Chim Acta       Date:  2013-12-07       Impact factor: 3.786

Review 8.  Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus.

Authors:  Andreas Pfützner; Anke H Pfützner; Martin Larbig; Thomas Forst
Journal:  Diabetes Technol Ther       Date:  2004-06       Impact factor: 6.118

9.  The emerging epidemic of obesity, diabetes, and the metabolic syndrome in china.

Authors:  Jia Shen; Abhinav Goyal; Laurence Sperling
Journal:  Cardiol Res Pract       Date:  2011-09-22       Impact factor: 1.866

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.